AmeriFlex Group’s Labcorp LH Stock Holding History

AmeriFlex Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-32	Closed	-$8.24K	–	1237
2025 Q2	$8.24K	Hold	32	–	–	﹤0.01%	751
2025 Q1	$7.45K	Hold	32	–	–	﹤0.01%	921
2024 Q4	$7.97K	Buy	+32	New	+$7.34K	﹤0.01%	830

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

AmeriFlex Group's LH Position: Q3 2025 in Review

AmeriFlex Group sold out of Labcorp (LH) in Q3 2025, closing a stake of 32 shares — an estimated $8.24K sold.

AmeriFlex Group first reported a position in LH in Q4 2024 and held it in 3 quarters. The position peaked at $8.24K in Q2 2025. 1,010 funds tracked by Wall St. Rank hold LH as of Q3 2025.

AmeriFlex Group reported no remaining Labcorp position as of Q3 2025 after selling out during the quarter.
AmeriFlex Group sold 32 Labcorp shares in Q3 2025, an estimated $8.24K.
AmeriFlex Group first reported a position in Labcorp in Q4 2024 and held it in 3 quarters.
AmeriFlex Group's Labcorp position peaked at $8.24K in Q2 2025.
1,010 funds tracked by Wall St. Rank held Labcorp as of Q3 2025.

Based on AmeriFlex Group's 13F filing for Q3 2025, filed 12 Nov 2025.